Abstract
Many applications of hematopoietic gene therapy require selection for clones with active transgene expression. However, it was unclear whether the clonal progeny of a retrovirally transduced hematopoietic stem cell would be capable of maintaining transgene expression through serial repopulation and multilineage differentiation. Such investigations require simultaneous analyses of clonality, multilineage activity and transgene copy numbers. Using a mouse model, the present study demonstrates that a single hematopoietic stem cell expressing a marker gene from one or two insertions of a simple retroviral vector actively maintains multilineage transgene expression in the vast majority (80–99%) of bone marrow and peripheral blood cells. Gene expression persisted through serial transplantations for at least 97 weeks post gene transfer and was observed in the lymphoid (B, T and NK cells), myeloid (CD11b+, Gr-1+), erythroid (Ter119+, mature red blood cells) and megakaryocytic (as indicated by platelets) progeny. Therefore, a single immunoselection for hematopoietic stem cells expressing the transgene in vivo was sufficient to establish a completely chimeric hematopoiesis. These observations imply that the retroviral vectors used in this study contain cis-elements that mediate expression through massive clonal expansion and multilineage differentiation, provided the insertion occurred in genetic loci permissive for expression in hematopoietic stem cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schiedlmeier B, Kuhlcke K, Eckert HG, Baum C, Zeller WJ, Fruehauf S . Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice Blood 2000 95: 1237–1248
Kiem HP, Andrews RG, Morris J, Peterson L, Heyward S, Allen JM, Rasko JE, Potter J, Miller AD . Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor Blood 1998 92: 1878–1886
Abonour R, Williams DA, Einhorn L, Hall KM, Chen J, Coffman J, Traycoff CM, Bank A, Kato I, Ward M, Williams SD, Hromas R, Robertson MJ, Smith FO, Woo D, Mills B, Srour EF, Cornetta K . Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells Nat Med 2000 6: 652–658
Li Z, Düllmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J, Forster M, Stocking C, Ostertag W, Wahlers A, Frank O, Kuehlcke K, Eckert HG, Fehse B, Baum C . Murine leukemia induced by retroviral gene marking Science 2002 296: 497
Wahlers A, Schwieger M, Li Z, Meier-Tackmann D, Lindemann C, Eckert HG, von Laer D, Baum C . Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells Gene Ther 2001 8: 477–486
Challita PM, Kohn DB . Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo Proc Natl Acad Sci USA 1994 91: 2567–2571
Riviere I, Brose K, Mulligan RC . Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells Proc Natl Acad Sci USA 1995 92: 6733–6737
Barklis E, Mulligan RC, Jaenisch R . Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells Cell 1986 47: 391–399
Klug CA, Cheshier S, Weissman IL . Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny Blood 2000 96: 894–901
Pawliuk R, Eaves CJ, Humphries RK . Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen Hum Gene Ther 1997 8: 1595–1604
Persons DA, Allay JA, Riberdy JM, Wersto, Donahue RE, Sorrentino BP, Nienhuis AW . Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells Nat Med 1998 4: 1201–1205
Bagley J, Aboody-Guterman K, Breakefield X, Iacomini J . Long-term expression of the gene encoding green fluorescent protein in murine hematopoietic cells using retroviral gene transfer Transplantation 1998 65: 1233–1240
Pawliuk R, Bachelot T, Wise RJ, Mathews-Roth MM, Leboulch P . Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy Nat Med 1999 5: 768–773
Kalberer CP, Pawliuk R, Imren S, Bachelot T, Takekoshi KJ, Fabry M, Eaves CJ, London IM, Humphries RK, Leboulch P . Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice Proc Natl Acad Sci USA 2000 97: 5411–5415
Qin G, Takenaka T, Telsch K, Kelley L, Howard T, Levade T, Deans R, Howard BH, Malech HL, Brady RO, Medin JA . Preselective gene therapy for Fabry disease Proc Natl Acad Sci USA 2001 98: 3428–3433
McInerney JM, Nawrocki JR, Lowrey CA . Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine Gene Ther 2000 7: 653–663
Rivella S, Callegari JA, May C, Tan CW, Sadelain M . The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites J Virol 2000 74: 4679–4687
Lemischka IR . What have we learned from retroviral marking of hematopoietic stem cells? Curr Top Microbiol Immunol 1992 177: 59–71
Keller G . Clonal analysis of hematopoietic stem cell development in vivo Curr Top Microbiol Immunol 1992 177: 41–58
Allay JA, Persons DA, Galipeau J, Riberdy JM, Ashmun RA, Blakley RL, Sorrentino BP . In vivo selection of retrovirally transduced hematopoietic stem cells Nat Med 1998 4: 1136–1143
Davis BM, Koc ON, Gerson SL . Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection Blood 2000 95: 3078–3084
Ragg S, Xu-Welliver M, Bailey J, D'Souza M, Cooper R, Chandra S, Seshadri R, Pegg AE, Williams DA . Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells Cancer Res 2000 60: 5187–5195
Sawai N, Zhou S, Vanin EF, Houghton P, Brent TP, Sorrentino BP . Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector Mol Ther 2001 3: 78–87
Jin L, Zeng H, Chien S, Otto KG, Richard RE, Emery DW, Blau CA . In vivo selection using a cell-growth switch Nat Genet 2000 26: 64–66
Antonchuk J, Sauvageau G, Humphries RK . HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation Exp Hematol 2001 29: 1125–1134
Baum C, Hegewisch-Becker S ., Eckert HG, Stocking C, Ostertag W. Novel retroviral vectors for efficient expression of the multidrug-resistance (mdr-1) gene in early hemopoietic cells J Virol 1995 69: 7541–7547
Fehse B, Richters A, Putimtseva-Scharf K, Klump H, Li Z, Ostertag W, Zander AR, Baum C . CD34 splice variant: an attractive marker for selection of gene-modified cells Mol Ther 2000 1: 448–456
Wahlers A ., Zipfel PF, Schwieger M, Ostertag W, Baum C. In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity J Virol 2002 76: 303–312
Halene S, Wang L, Cooper RM, Bockstoce DC, Robbins PB, Kohn DB . Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector Blood 1999 94: 3349–3357
Fehse B, Uhde A, Fehse N, Eckert HG, Clausen J, Ruger R, Koch S, Ostertag W, Zander AR, Stockschlader M . Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (dLNGFR) gene Hum Gene Ther 1997 8: 1815–1824
de Wynter EA, Ryder D, Lanza F, Nadali G, Johnsen H, Denning-Kendall P, Thing-Mortensen B, Silvestri F, Testa NG . Multicentre European study comparing selection techniques for the isolation of CD34+ cells Bone Marrow Transplant 1999 23: 1191–1196
Speck NA, Renjifo B, Golemis E, Fredrickson TN, Hartley JW, Hopkins N . Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity Genes Dev 1990 4: 233–2422
Grande A, Piovani B, Aiuti A, Ottolenghi S, Mavilio F, Ferrari G . Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells Blood 1999 93: 3276–3285
Moreau-Gaudry F, Xia P, Jiang G, Perelman NP, Bauer G, Ellis J, Surinya KH, Mavilio F, Shen CK, Malik P . High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors Blood 2001 98: 2664–2672
Tisdale J, Sadelain M . Toward gene therapy for disorders of globin synthesis Semin Hematol 2001 38: 382–392
Agarwal M, Austin TW, Morel F, Chen J, Bohnlein E, Plavec I . Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells J Virol 1998 72: 3720–3728
Gong JK . Anemic stress as a trigger of myelogenous leukemia in rats rendered leukemia-prone by x-ray Science 1971 174: 833–835
Rubin H . The role of selection in progressive neoplastic transformation Adv Cancer Res 2001 83: 159–207
Laker C, Meyer J, Schopen A, Friel J, Heberlein C, Ostertag W, Stocking C . Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation J Virol 1998 72: 339–348
Hamaguchi I, Woods NB, Panagopoulos I, Andersson E, Mikkola H, Fahlman C, Zufferey R, Carlsson L, Trono D, Karlsson S . Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro J Virol 2000 74: 10778–10784
Cherry SR, Biniszkiewicz D, van Parijs L, Baltimore D, Jaenisch R . Retroviral expression in embryonic stem cells and hematopoietic stem cells Mol Cell Biol 2000 20: 7419–7426
Artelt P, Grannemann R, Stocking C, Friel J, Bartsch J, Hauser H . The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells Gene 1991 99: 249–254
Acknowledgements
This work was supported by the Deutsche Krebshilfe (10–1456-Ba2, animal models), the BMBF (development of selection systems BMBF 01KV981, and BMBF 0312173 via CellTec), the VolkswagenStiftung, and the DAAD (personal grant to ZL). ZL also received support of the National Science Foundation of China (39900064), Guangdong Provincial Natural Science Foundation of China (990105) and the Chinese Ministry of Education (grants 2000/11 and 2000/65). The Heinrich Pette Institute is supported financially by the Bundesministerium für Gesundheit and by the Freie und Hansestadt Hamburg. The authors wish to thank Gökhan Arman-Kalcek, Dung Ung, Cordula Grüttner, Susanne Feldhaus and Maike Ziesnitz for expert technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, Z., Fehse, B., Schiedlmeier, B. et al. Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell. Leukemia 16, 1655–1663 (2002). https://doi.org/10.1038/sj.leu.2402619
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402619
Keywords
This article is cited by
-
Cytological characterization of murine bone marrow and spleen hematopoietic compartments for improved assessment of toxicity in preclinical gene marking models
Annals of Hematology (2013)
-
Stem Cell Marking With Promotor-deprived Self-inactivating Retroviral Vectors Does Not Lead to Induced Clonal Imbalance
Molecular Therapy (2009)
-
Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants
Bone Marrow Transplantation (2005)
-
A novel ‘sort-suicide’ fusion gene vector for T cell manipulation
Gene Therapy (2002)